MANAGEMENT OF LOCALLY ADVANCED AND DISSEMINATED BREAST CANCER-CHEMOTHERAPYBISEL HF.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 4; PP. 1079-1083; BIBL. 51 REF.Article

PHASE II CLINICAL TRIAL OF ISOPHOSPHAMIDE (NSC-109724) IN PATIENTS WITH ADVANCED BREAST CANCERAHMANN DL; BISEL HF; HAHN RG et al.1974; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1974; VOL. 58; NO 6; PP. 861-865; BIBL. 3 REF.Article

THERAPEUTIC OOPHORECTOMY IN DISSEMINATED CARCINOMA OF THE BREAST.PUGA FJ; WELCH JS; BISEL HF et al.1976; ARCH. SURG.; U.S.A.; DA. 1976; VOL. 111; NO 8; PP. 877-880; BIBL. 5 REF.Article

DISSEMINATED BREAST CANCER: EVALUATION OF HORMONAL THERAPY UTILIZING STILBESTROL AND MEDROGESTONE (AY-62022) SINGLY AND IN COMBINATION = CANCER DU SEIN DISSEMINE: VALEUR DE LA THERAPEUTIQUE HORMONALE PAR STILBOESTROL ET MEDROGESTONE (AY-62022) SEULES OU ASSOCIEESAHMANN DL; HAHN RG; BISEL HF et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 3; PP. 651-653; BIBL. 11REF.Miscellaneous

CLINICAL EVALUATION OF 5-(3,3-DIMETHYL-1-TRIAZENO) IMIDAZOLE-4-CARBOXAMIDE (NSC-45388), MELPHALAN (NSC-8806), AND HYDROXYUREA (NSC-32065) IN THE TREATMENT OF DISSEMINATED MALIGNANT MELANOMAAHMANN DL; HAHN RG; BISEL HF et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 3; PP. 369-372; BIBL. 7REF.Serial Issue

A CLINICAL TRIAL ADRIAMYCIN (NSC 123127) IN ADVANCED SARCOMAS.CREAGAN ET; HAHN RG; AHMANN DL et al.1977; ONCOLOGY; SUISSE; DA. 1977; VOL. 34; NO 2; PP. 90-91Article

EVALUATION OF VP-16 AND THE COMBINATION OF ADRIAMYCIN AND VINCRISTINE IN ADVANCED BREAST CANCER.EAGAN RT; AHMANN DL; BISEL HF et al.1976; ONCOLOGY; SWITZ.; DA. 1976; VOL. 33; NO 3; PP. 146-148; BIBL. 12 REF.Article

A COMPARATIVE STUDY OF 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA (NSC79037) AND IMIDAZOLE CARBOXAMIDE (NSC 45388) WITH VINCRISTINE (NSC 67574) IN THE PALLIATION OF DISSEMINATED MALIGNANT MELANOMA = ETUDE COMPARATIVE DE LA CHLORO-2 ETHYL-1 CYCLOHEXYL-5 NITROSO-1 UREE (NSC79037) ET DE L'IMIDAZOLE CARBOXAMIDE (NSC45388) ASSOCIE A LA VINCRISTINE (NSC67574) DANS LE TRAITEMENT DU MELANOME MALIN DISSEMINEAHMANN DL; HAHN RG; BISEL HF et al.1972; CANCER RES.; U.S.A.; DA. 1972; VOL. 32; NO 11; PP. 2432-2434; BIBL. 5REF.Serial Issue

COMPARATIVE STUDY OF METHYL-CCNU(NSC-95441) WITH CYCLOPHOSPHAMIDE (NSC-26271) AND 5-(3,3 DIMETHYL-1-TRIAZENO)IMIDAZOLE-4-CARBOXAMIDE (NSC-45388) WITH VINCRISTINE (NSC-67574) IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMAAHMANN DL; HAHN RG; BISEL HF et al.1975; CANCER CHEMOTHERAPY REP.; U.S.A.; DA. 1975; VOL. 59; NO 2; PP. 451-453; BIBL. 5REF.Article

CONTROLLED EVALUATION OF ADRIAMYCIN (NSC-123127) IN PATIENTS WITH DISSEMINATED BREAST CANCERAHMANN DL; BISEL HF; EAGAN RT et al.1974; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1974; VOL. 58; NO 6; PP. 877-882; BIBL. 7 REF.Article

MALIGNANT NONFUNCTIONING PARAGANGLIOMA OF THE RETROPERITONEUM PRODUCING RENOVASCULAR HYPERTENSIONMUNDIS RJ; BISEL HF; SHEPS SG et al.1982; MAYO CLINIC PROCEEDINGS; ISSN 0025-6196; USA; DA. 1982; VOL. 57; NO 10; PP. 661-664; BIBL. 16 REF.Article

PHASE II STUDY OF CHLOROZOTOCIN IN ADVANCED BREAST CANCEREDMONSON JH; GREEN SJ; INGLE JN et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 5-6; PP. 537-538; BIBL. 3 REF.Article

COMPLETE RESPONDERS TO CHEMOTHERAPY IN METASTATIC BREAST CANCER: CHARACTERIZATION AND ANALYSISDECKER DA; AHMANN DL; BISEL HF et al.1979; J.A.M.A.; USA; DA. 1979; VOL. 242; NO 19; PP. 2075-2079; BIBL. 15 REF.Article

PHASE II STUDY OF VP-16-213 VERSUS DIANHYDROGALACTITOL IN PATIENTS WITH METASTATIC MALIGNANT MELANOMA.AHMANN DL; BISEL HF; EDMONSON JH et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 11; PP. 1681-1682; BIBL. 4 REF.Article

AN EVALUATION OF EARLY OF DELAYED ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER UNDERGOING OOPHORECTOMY: A LATER ANALYSISAHMANN DL; GREEN SJ; BISEL HF et al.1982; AMERICAN JOURNAL OF CLINICAL ONCOLOGY; ISSN 512273; USA; DA. 1982; VOL. 5; NO 4; PP. 355-358; BIBL. 10 REF.Article

PHASE II STUDY OF ICRF-159 VERSUS COMBINATION CIS-DICHLORODIAMMINEPLATINUM (II) AND DTIC IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMA.AHMANN DL; EDMONSON JH; FRYTAK S et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 1; PP. 151-153; BIBL. 10 REF.Article

AN EVALUATION OF EARLY OR DELAYED ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCER UNDERGOING OOPHORECTOMY.AHMANN DL; O'CONNELL MJ; HAHN RG et al.1977; NEW ENGL. J. MED.; U.S.A.; DA. 1977; VOL. 297; NO 7; PP. 356-360; BIBL. 10 REF.Article

CLINICAL COMPARISON OF ADRIAMYCIN AND A COMBINATION OF METHYL-CCNU AND IMIDAZOLE CARBOXAMIDE IN DISSEMINATED MALIGNANT MELANOMAAHMANN DL; BISEL HF; EDMONSON JH et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 19; NO 6; PP. 821-824; BIBL. 9 REF.Article

PHASE II STUDIES OF DIANHYDROGALACTITOL-BASED COMBINATION CHEMOTHERAPY FOR RECURRENT BRAIN TUMORSEAGAN RT; CREAGAN ET; BISEL HF et al.1981; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1981; VOL. 38; NO 1; PP. 4-6; BIBL. 9 REF.Article

RANDOMIZED PHASE II TRIAL OF RUBIDAZONE AND ADRIAMYCIN IN WOMEN WITH ADVANCED BREAST CANCERINGLE JN; AHMANN DL; O'FALLON JR et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 65; NO 11-12; PP. 1701-1705; BIBL. 11 REF.Article

PHASE II EVALUATION OF VP-16-213 (NSC-141540) AND CYTEMBENA (NSC-104801) IN PATIENTS WITH ADVANCED BREAST CANCERAHMANN DL; BISEL HF; EAGAN RT et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 5; PP. 633-635; BIBL. 1 REF.Article

PHASE II STUDY OF MAYTANSINE AND CHLOROZOTOCIN IN PATIENTS WITH DISSEMINATED MALIGNANT MELANOMAAHMANN DL; FRYTAK S; KVOLS LK et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 4-5; PP. 721-723; BIBL. 6 REF.Article

A PRELIMINARY STUDY OF CYCLOPHOSPHAMIDE (NSC-26271), ADRIAMYCIN (NSC-123127) IMIDAZOLE CARBOXAMIDE (NSC-45388), AND ACTINOMYCIN D (NSC-3053) WITH OR WITHOUT MER-BCG IN PATIENTS WITH ADVANCED SARCOMAS.CREAGAN ET; EDMONSON JH; HAHN RG et al.1978; MED. PEDIATR. ONCOL.; U.S.A.; DA. 1978; VOL. 4; NO 1; PP. 85-86; BIBL. 5 REF.Article

PHASE II STUDY OF DIANHYDROGALACTITOL AND ICRF-159 IN PATIENTS WITH ADVANCED BREAST CANCER PREVIOUSLY EXPOSED TO CYTOTOXIC CHEMOTHERAPY.AHMANN DL; O'CONNELL MJ; BISEL HF et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 1; PP. 81-82; BIBL. 5 REF.Article

HEXAMETHYLMELAMINE AS A SINGLE AGENT IN THE TREATMENT OF SMALL-CELL CARCINOMA OF THE LUNGGOLDSWEIG HG; EDGERTON F; REDDEN CS et al.1982; AM. J. CLIN. ONCOL.; ISSN 512273; USA; DA. 1982; VOL. 5; NO 3; PP. 267-272; BIBL. 19 REF.Article